Form 144: Minor MetLife insider sale of 360 shares disclosed

Rhea-AI Filing Summary

MetLife, Inc. (MET) filed a Form 144 with the SEC disclosing a proposed sale of 360 common shares through Barclays Capital on or after 20 June 2025. The shares have an aggregate market value of $28,278, compared with the company’s 671,297,826 shares outstanding, representing less than 0.0001 % of total equity—an immaterial amount from an ownership-dilution perspective.

The filer originally acquired the shares on 29 May 2015 via a purchase from Goldman Sachs for cash. The notice affirms the seller’s representation that no undisclosed material adverse information is known.

Recent trading history: in the last three months, related MetLife accounts collectively sold 686 shares for $55,391.75 in gross proceeds. These transactions, combined with the planned 360-share disposition, remain de minimis relative to MetLife’s market capitalization and average daily trading volume. No financial performance data, strategic updates or governance changes accompany the filing.

Given the modest size and routine nature of the transaction, the filing is unlikely to influence MetLife’s valuation or trading dynamics.

Insights

Securities Analyst

TL;DR: Routine Form 144 for 360 shares (<$30k); negligible impact on MET stock.

The filing signals a tiny planned sale by an internal MetLife account, amounting to only 0.0001 % of shares outstanding. Aggregate value is immaterial, and recent similar disposals total ~686 shares. No strategic, operational, or financial information is included, and the signer attests to possessing no non-public adverse data. Given MetLife’s multi-billion-dollar market cap and daily turnover, this disclosure is a compliance formality with no expected valuation or liquidity effect.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays Capital 745 Seventh Ave New York NY 10019	360	28278	671297826	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/29/2015	Purchase	GOLDMAN SACHS			360	06/03/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	335	27590.6
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	77	6341.72
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	47	3870.92
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	6	494.16
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/13/2025	221	17094.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did MetLife (MET) disclose in the latest Form 144?

A planned sale of 360 common shares valued at $28,278 through Barclays Capital on or after 20 Jun 2025.

How significant is the 360-share sale relative to MetLife’s shares outstanding?

The proposed sale represents <0.0001 % of the 671,297,826 shares outstanding—an immaterial amount.

What were the past three-month insider sales reported in the filing?

MetLife-related accounts sold 686 shares for $55,391.75 in gross proceeds between 21 Mar 2025 and 13 Jun 2025.

Does the Form 144 include any new financial or strategic information about MetLife?

No. The filing is limited to a routine compliance notice about a small share sale; it provides no operational or earnings updates.